Home Healthcare IT United Kingdom Epigenetics Market Size & Share Report | 2032

United Kingdom Epigenetics Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents and Kits, Enzymes, Software, Service), By Applications (Oncology, Autoimmune Diseases, Metabolic Diseases, CNS/Pain Diseases, Cardiovascular Diseases, Others), By End-User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutions, Contract Research Organizations (CROS), Others) and Forecasts, 2024-2032

Report Code: SRHI56264DR
Last Updated : Jun 07, 2024
Author : Straits Research
Starting From
USD 2300
Buy Now

Table Of Content

  1. Executive Summary

    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  2. ESG Trends

  3. ESG Trends

    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Instruments
        1. By Value
      3. Reagents and Kits
        1. By Value
        2. Antibodies
          1. Antibodies By Value
        3. ChiP-seq Kits
          1. ChiP-seq Kits By Value
        4. Bisulfite Conversion Kits
          1. Bisulfite Conversion Kits By Value
        5. Whole Genome Amplification Kits
          1. Whole Genome Amplification Kits By Value
        6. 5-hmC and 5-mC Analysis Kits
          1. 5-hmC and 5-mC Analysis Kits By Value
        7. Histones
          1. Histones By Value
        8. Other Kits and Reagents
          1. Other Kits and Reagents By Value
      4. Enzymes
        1. By Value
        2. DNA-modifying Enzymes
          1. DNA-modifying Enzymes By Value
        3. Protein-modifying Enzymes
          1. Protein-modifying Enzymes By Value
        4. Other Enzymes
          1. Other Enzymes By Value
      5. Software
        1. By Value
      6. Service
        1. By Value
    3. By Applications
      1. Introduction
        1. Applications By Value
      2. Oncology
        1. By Value
      3. Autoimmune Diseases
        1. By Value
      4. Metabolic Diseases
        1. By Value
      5. CNS/Pain Diseases
        1. By Value
      6. Cardiovascular Diseases 
        1. By Value
      7. Others
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Pharmaceutical and Biotechnology Companies
        1. By Value
      3. Academic and Research Institutions
        1. By Value
      4. Contract Research Organizations (CROS)
        1. By Value
      5. Others
        1. By Value
    1. United Kingdom Epigenetics Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Illumina Inc
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Abcam Plc
    3. Active Motif Inc
    4. Agilent Technologies Inc
    5. Hologic Inc
    6. Zymo Research
    7. Merck Millipore
    8. PerkinElmer Inc
    9. QIAGEN NV
    10. Thermo Fisher Scientific Inc
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  4. Disclaimer

Related Reports

Global Report
The global reproductive genetics market size was worth USD 4,520.12 million in 2022. It is anticipated to reach an expected value of USD 14,500.82 million by 2031 growing at a CAGR of 12.2% during the forecast period (2023-2031). The need for prenat
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report


We are featured on :